济川药业(600566.SH)：抗流感1类创新药济可舒适应症适用于既往健康的成人单纯性甲型和乙型流感患者的治疗

Core Viewpoint - Jichuan Pharmaceutical (600566.SH) has introduced a new antiviral drug, Jike Shushi, which is designed to treat patients with uncomplicated type A and B influenza, providing a new treatment option for previously healthy adults [1] Group 1 - The drug Jike Shushi is classified as a first-class innovative drug for the treatment of influenza [1] - N3H2N3 is identified as a subtype of the influenza A virus [1] - The use of the drug should adhere to the instructions provided in the drug label and the guidance of healthcare professionals [1]